TFF PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.95 USD | -10.55% |
|
-3.94% | -72.22% |
Chart calendar TFF Pharmaceuticals, Inc.
698f7aebd84fbcb5109f5.tEaiXhhK1zeqF2QlQ8-Ab29rlKXy9n3mFqVjtEfdjHE.2CPUKGwbglXiXjcRDo6yBy0S0O7KpBy8ZeMxgA3r4EPCf9gYbAKPcthPNQ~fa925a5485cc3e0defafe48778cd58b4
Upcoming events on TFF Pharmaceuticals, Inc.
Past events on TFF Pharmaceuticals, Inc.
| 09/05/2024 | Q1 2024 Earnings Release (Projected) |
| 13/04/2024 | International Society for Heart and Lung Transplantation Meeting |
| 29/03/2024 01:35 am | Q4 2023 Earnings Release |
| 28/03/2024 02:00 am | TFF TAC and TFF VORI Phase 2 Study Results Call |
| 19/03/2024 12:00 am | Roth Conference |
| 26/01/2024 12:40 pm | Advances Against Aspergillosis & Mucormycosis Conference |
| 19/12/2023 07:00 pm | TFF VORI and TFF TAC Phase 2 Trial Call |
| 07/12/2023 | Benchmark Company Discovery Conference |
| 21/11/2023 09:30 pm | Annual General Meeting |
| 15/11/2023 03:00 am | Q3 2023 Earnings Call |
| 15/11/2023 02:35 am | Q3 2023 Earnings Release |
| 12/10/2023 07:00 pm | Roth Healtcare Opportunities Conference |
| 10/10/2023 05:30 pm | JonesTrading Healthcare Summit |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 15/08/2023 08:30 pm | Q2 2023 Earnings Call |
| 15/08/2023 03:35 pm | Q2 2023 Earnings Release |
| 09/06/2023 06:30 pm | Jefferies Global Healthcare Conference |
| 12/05/2023 01:35 am | Q1 2023 Earnings Release |
| 10/05/2023 09:45 pm | Sidoti Micro-Cap Virtual Conference |
| 13/03/2023 11:00 pm | Roth Conference - Fireside Chat |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,25 - | 0,09 0,68 -86.96% | 0,50 0,22 123.84% | 0,73 0,82 -10.5% | 0,60 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -18,7 -17,4 -7.19% | -31,8 -28,6 -11% | -31,8 -31,7 -0.25% | -21,9 -21,0 -4.24% | -23,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -18,6 -17,3 -7.5% | -31,0 -27,9 -11.13% | -31,8 -31,5 -0.87% | -21,2 -21,0 -1.4% | -23,7 |
|
Net income Million USD | Released Forecast Spread | -18,6 -17,5 -6.1% | -31,0 -27,9 -11.13% | -31,8 -31,5 -0.87% | -21,2 -21,0 -1.4% | -23,7 |
|
EPS USD | Released Forecast Spread | -22,8 -21,6 -5.2% | -31,3 -28,2 -10.95% | -26,5 -28,6 7.42% | -11,9 -11,7 -1.2% | -7,28 |
| Announcement Date | 10/03/21 | 24/03/22 | 31/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,01 0,63 -98.08% | 0,07 0,05 34.88% | 0,03 0,00 - | 0,09 0,00 - | 0,31 0,02 1463.9% | 0,05 0,50 -89.71% | 0,33 0,10 233.35% | 0,23 0,10 134.76% | 0,11 0,20 -42.84% | 0,15 | 0,15 | 0,15 | 0,15 |
|
EBIT Million USD | Released Forecast Spread | -10,1 -6,94 -45.41% | -8,44 -9,82 14.07% | -8,77 -8,79 0.18% | -7,28 -8,66 15.97% | -7,38 -7,22 -2.24% | -7,09 -7,40 4.2% | -5,02 -7,29 31.13% | -4,42 -5,28 16.26% | -5,37 -4,48 -19.86% | -5,45 | -5,57 | -6,06 | -6,63 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,0 -6,94 -44.86% | -8,38 -9,68 13.51% | -8,75 -8,65 -1.1% | -7,27 -8,57 15.14% | -7,37 -7,10 -3.86% | -7,05 -7,37 4.35% | -5,02 -7,18 30.08% | -4,41 -5,27 16.32% | -4,76 -4,47 -6.57% | -5,44 | -5,56 | -6,05 | -6,62 |
|
Net income Million USD | Released Forecast Spread | -10,0 -6,94 -44.86% | -8,38 -9,68 13.51% | -8,75 -8,65 -1.1% | -7,27 -8,57 15.14% | -7,37 -7,10 -3.86% | -7,05 -7,37 4.35% | -5,02 -7,18 30.08% | -4,41 -5,27 16.32% | -4,76 -4,47 -6.57% | -5,44 | -5,56 | -6,05 | -6,62 |
|
EPS USD | Released Forecast Spread | -10,0 -6,83 -46.34% | -8,75 -9,50 7.89% | -8,50 -8,00 -6.25% | -7,25 -8,33 13% | -2,50 -6,13 59.18% | -4,75 -5,00 5% | -3,50 -4,88 28.21% | -2,25 -2,75 18.18% | -11,4 -1,89 -505.29% | -2,20 | -2,11 | -1,53 | -1,68 |
| Announcement Date | 24/03/22 | 11/05/22 | 11/08/22 | 14/11/22 | 31/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for TFF Pharmaceuticals, Inc.
| 10/05/2024 04:30 pm | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 10/05/2024 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 10/05/2024 01:40 am | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | OMNIAB, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:35 am | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- TFFP Stock
- Calendar TFF Pharmaceuticals, Inc.